BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7142436)

  • 1. Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy.
    Smith PS; McClure J
    J Clin Pathol; 1982 Nov; 35(11):1283-93. PubMed ID: 7142436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The localization of aluminium and other elements in bone tissue of a case of renal osteodystrophy with an associated dialysis encephalopathy syndrome.
    McClure J; Smith PS
    J Pathol; 1984 Apr; 142(4):293-9. PubMed ID: 6716213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy.
    Boyce BF; Eider HY; Fell SG; Nicholson WA; Smith GD; Dempster DW; Gray CC; Boyle IT
    Scan Electron Microsc; 1981; (Pt 3):329-37. PubMed ID: 7330581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
    McClure J; Fazzalari NL; Fassett RG; Pugsley PG
    J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone histoquantitative findings and histochemical staining reactions for aluminium in chronic renal failure patients treated with haemodialysis fluids containing high and low concentrations of aluminium.
    McClure J; Fazzalari NL; Fassett RG; Pugsley DJ
    J Clin Pathol; 1983 Nov; 36(11):1281-7. PubMed ID: 6630577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism].
    de Vernejoul MC
    Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.
    Boyce BF; Byars J; McWilliams S; Mocan MZ; Elder HY; Boyle IT; Junor BJ
    J Clin Pathol; 1992 Jun; 45(6):502-8. PubMed ID: 1624597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of avascular necrosis of the femoral head in aluminium-related renal osteodystrophy and the role of endochondral ossification in the repair process.
    McClure J; Smith PS
    J Clin Pathol; 1983 Mar; 36(3):260-8. PubMed ID: 6402524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.
    Pizzarelli F; Ballanti P; Costantini S; Mocetti P; Giordano R; Della Rocca C; Fabrizi F; Bonucci E; Maggiore Q
    Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum associated bone disease: clinico-pathologic correlation.
    Ihle B; Buchanan M; Stevens B; Marshal A; Plomley R; d'Apice A; Kincaid-Smith P
    Am J Kidney Dis; 1982 Sep; 2(2):255-63. PubMed ID: 7124722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dialysis osteomalacia with desferrioxamine.
    Brown DJ; Dawborn JK; Ham KN; Xipell JM
    Lancet; 1982 Aug; 2(8294):343-5. PubMed ID: 6124756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
    Charhon SA; Chavassieux PM; Meunier PJ; Accominotti M
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1613-4. PubMed ID: 3924189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemic osteomalacia due to aluminium toxicity.
    Boyce BF; Fell GS; Elder HY; Junor BJ; Elliot HL; Beastall G; Fogelman I; Boyle IT
    Lancet; 1982 Nov; 2(8306):1009-13. PubMed ID: 6127501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.
    Ellis HA; McCarthy JH; Herrington J
    J Clin Pathol; 1979 Aug; 32(8):832-44. PubMed ID: 389958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.